Your session is about to expire
← Back to Search
MuST AKT for Kidney Transplant (MuST AKT Trial)
N/A
Waitlist Available
Led By Dr. Shojai
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
English speaking
No obvious contraindication to kidney transplantation
Must not have
Candidate for multi-organ transplant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from start date to end date of study recruitment, up to 1 year
Awards & highlights
Summary
This trial is testing a new intervention to help patients with kidney failure identify and communicate with potential living donors. The intervention includes support from a multidisciplinary team to educate the patients' social network. The goal is to increase living kidney donations by 34%.
Who is the study for?
This trial is for English-speaking patients with kidney failure who have completed an 'introduction to kidney transplant' module and are eligible for a transplant. It's not for those who've had previous transplants, have high psychosocial risk scores, already identified a donor, can't read basic health-related English or need multiple organ transplants.
What is being tested?
The MuST AKT intervention is being tested to see if it helps patients with kidney failure find living kidney donors by providing personalized support from a multidisciplinary team to educate their social networks about donation.
What are the potential side effects?
Since the intervention involves educational and support services rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological stress during the process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English.
Select...
I am a suitable candidate for a kidney transplant.
Select...
I have completed the kidney transplant introduction module.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am eligible for a transplant involving multiple organs.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from start date to end date of study recruitment, up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from start date to end date of study recruitment, up to 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Living Kidney Donor Evaluation Started
Secondary study objectives
Contact Living Donor Services
Identified potential advocates
Living Kidney Donor Evaluation Completed
+1 moreOther study objectives
Advocate and donor attendance at last intervention session
Consent rate
Conversation started
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
This arm will receive the MuST AKT intervention, which is a multidisciplinary, tailored person-centered behavioural intervention designed to "help and enable" the potential kidney transplant recipients to achieve what is required to receive a living donor kidney transplantation.
Group II: Usual Care (control)Active Control1 Intervention
In the usual care (control) condition, participants will go through the current standard of care, which is a social worker assessment.
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
913 Previous Clinical Trials
390,395 Total Patients Enrolled
University Hospital FoundationOTHER
7 Previous Clinical Trials
1,229 Total Patients Enrolled
Dr. ShojaiPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
64 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English.I am eligible for a transplant involving multiple organs.I am a suitable candidate for a kidney transplant.Your SIPAT score is higher than 20, indicating significant psychological and social challenges that may affect your ability to undergo a transplant.You have been identified as a possible kidney donor for someone else.You have had an organ transplant in the past.I have completed the kidney transplant introduction module.You have a score below 19 on a test that measures how well you can read and understand medical information in English.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Usual Care (control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger